Chinook Therapeutics - Delisted Stock
Chinook Therapeutics is currently unavailable and cannot be used in your analysis. The information on this page reflects the last day Chinook Therapeutics was actively traded.
Valuation
Check how we calculate scores
Chinook Therapeutics Risk Profiles
Investors will always prefer to have the highest possible return on investment while minimizing volatility. Chinook Therapeutics market risk premium is the additional return an investor will receive from holding Chinook Therapeutics long position in a well-diversified portfolio.
Mean Deviation | 2.8 | |||
Semi Deviation | 1.72 | |||
Standard Deviation | 7.6 | |||
Variance | 57.7 |
View Chinook Therapeutics Related Equities
Risk & Return | Correlation |
Chinook Therapeutics Corporate Management
Tom Frohlich | Chief Officer | Profile | |
Jodi Jamieson | VP HR | Profile | |
MS MD | Sr Strategy | Profile | |
Eric MBA | Chief Officer | Profile | |
Kirk JD | Sr Counsel | Profile | |
Alan MD | Ex Officer | Profile | |
Andrew DVM | Chief Officer | Profile |
Still Interested in Chinook Therapeutics?
Investing in delisted delisted stocks can be risky, as the stock is no longer traded on a public exchange and can therefore be difficult to sell. Delisting typically occurs when a company has failed to meet exchange requirements or has been acquired. Before investing, it's important to thoroughly research the company, including its financial health and prospects for the future, as well as the reasons for its delisting. Additionally, it may be difficult to find accurate and up-to-date information on the company and its stock.
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. You can also try the Transaction History module to view history of all your transactions and understand their impact on performance.
Other Consideration for investing in Chinook Stock
If you are still planning to invest in Chinook Therapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Chinook Therapeutics' history and understand the potential risks before investing.
Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
Bonds Directory Find actively traded corporate debentures issued by US companies | |
Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
Commodity Directory Find actively traded commodities issued by global exchanges | |
Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
Money Managers Screen money managers from public funds and ETFs managed around the world | |
Transaction History View history of all your transactions and understand their impact on performance | |
Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
Fundamental Analysis View fundamental data based on most recent published financial statements |